Biosensors to be removed from FDA's Import Alert list
BIOSENSORS International Group said it had received confirmation from the US Food and Drug Administration (FDA) on Tuesday that it would be removed from the Import Alert given its willingness to be inspected.
The heart device manufacturer said this in a statement to Singapore Exchange on Wednesday to clarify certain media reports that its products have been banned by the FDA.
The FDA had placed Biosensors' critical care products on the Import Alert because it thought that the firm had refused the scheduled routine inspection as it had not responded to the notification letter within the stipulated five-day window, explained the firm.
Biosensors said it received the letter on Dec 21, 2015, and responded that it would welcome the inspection on Jan 11, 2016, attributing the delay to "administrative errors during the holidays".
The company reiterated that it views all regulatory compliance and inspections with utmost importance, including the FDA.
Shares of Biosensors slipped one Singapore cent or 1.3 per cent to 77.5 Singapore cents on Wednesday.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action